RetiSpec is very proud to be featured in September's issue of Scientific American exploring how eye tests can help to diagnose Alzheimer's disease
We use advanced imaging technology to detect disease biomarkers throughout the eye

1 / Eye Examination
We take images by combining standard equipment available in most eye clinics with a specialized camera -- this means that the experience is familiar and comfortable.

2 / Data-Rich Images
Our hyperspectral camera can captures data-rich images with a broad spectrum of information, providing the basis for detailed analysis of a large area for more accurate results

3 / Artificial Intelligence
Our AI identifies early signs of Alzheimer’s disease by comparing the captured images to others where the biological signatures associated with these neurodegenerative diseases are present.

Our Solution
We partner with pharmaceutical companies and leading research institutions to accelerate research and integrate seamlessly into the clinical workflow